Dementia care is one of the critical issues facing the aged care industry. About 500,000 Australians currently live with the brain disorder condition, and this is tipped to rise to 1.1 million in a generation.
How to effectively provide quality care for people living with dementia was a key element of the royal commission into aged care, which found the complex care required was an ongoing challenge for the industry.
More than half the residents in aged care homes have a diagnosis of dementia. “We are deeply concerned that so many aged care providers do not seem to have the skills and capacity required to care adequately for people living with dementia,” the final report said.
To address these skills gaps, Dementia Australia, developed two applications to help with the learning and development of carers. Australian Health Journal spoke with Dr Tanya Petrovich, Dementia Australia’s Business Innovation Manager on how these platforms help those caring for people with dementia to understand, and improve their communication with people experiencing dementia. Tanya also spoke about last year Dementia Australia winning two Future of Ageing Awards in the Dementia Care and Business Technology categories.
Winner of Dementia Care category in the 2022 Future of Ageing Awards: Talk with Ted
The Talk With Ted program, created by Dementia Australia, simulates a typical chat including emotional and verbal responses between a carer and the resident.
“This type of experiential learning, that is both engaging and innovative, helps people to recall exactly what they’ve learned and makes them more likely to implement these new skills – which means better care for our loved ones living with dementia,” said Dementia Australia’s CEO Maree McCabe at the time of the launch.
The AI platform was created through a collaboration between Dementia Australia’s Centre for Dementia Learning and Deakin University’s Applied Artificial Intelligence Institute (A²I²), care workers, and was informed by real-life experiences of people living with dementia. Funding came from the Rosemary Norman Foundation.
Winner of Business Technology category in the 2022 Future of Ageing Awards: Ask Annie
There are more than 130,000 people working in-home support and community care across Australia. These people play a vital role for people living with dementia, their families, and carers.
‘Ask Annie’ is a virtual tool for community care workers providing dementia care in the home. Annie guides users through a range of scenarios, based on real-life experiences, to strengthen their dementia care skills.
The mobile app offers short, self-paced learning modules to help care workers refresh their skills and learn tips and tools to provide better care to people living with dementia. These are referred to as micro-learning training, that is accessible whenever a care worker wants to schedule a quick 10 or 15-minute lesson.
Ask Annie was developed by Dementia Australia with Deakin University’s Applied Artificial Intelligence Institute (A²I²), with the financial support of Gandel Philanthropy.
Produced with kind assistance from Inside Ageing and Future of Ageing Awards.
-
Detection and prevention of Alzheimer’s Disease and Related Dementias
Professor Vicky Vass serves as the Chief Executive Officer of Alzheimer’s Research Australia, which is based in Perth, Western Australia. Australian Health Journal met with Professor Vass to hear of the organisation’s mission to solve the mysteries surrounding Alzheimer’s disease, and focus on detection as the key to their efforts.
-
Stroke care advances in translated research
New nurse-led protocols for stroke patients, based on ACU research, led by the Nursing Research Institute, have resulted in changes to policy, guidelines and clinical practice in Europe and Australia. The protocols were developed through the Quality in Acute Stroke Care (QASC) Trial (published in the Lancet, 2011) to manage fever, hyperglycaemia and swallowing (FeSS) post-stroke.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
